Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2243
Gene Symbol: FGA
FGA 		0.500 Biomarker phenotype GENOMICS_ENGLAND
Entrez Id: 10544
Gene Symbol: PROCR
PROCR 		0.330 Biomarker phenotype GENOMICS_ENGLAND
Entrez Id: 2147
Gene Symbol: F2
F2 		0.580 Biomarker phenotype CTD_human Effect of sodium pentosan polysulphate on the thrombogenicity of prothrombin complex concentrates. 1279834 1992
Entrez Id: 2159
Gene Symbol: F10
F10 		0.300 Biomarker phenotype CTD_human Effect of sodium pentosan polysulphate on the thrombogenicity of prothrombin complex concentrates. 1279834 1992
Entrez Id: 2158
Gene Symbol: F9
F9 		0.300 Biomarker phenotype CTD_human Effect of sodium pentosan polysulphate on the thrombogenicity of prothrombin complex concentrates. 1279834 1992
Entrez Id: 5328
Gene Symbol: PLAU
PLAU 		0.500 Therapeutic phenotype CTD_human [Treatment of massive arterial thrombosis caused by thrombocytopenia induced by heparin with local thrombolysis]. 2106299 1990
Entrez Id: 5327
Gene Symbol: PLAT
PLAT 		0.320 Therapeutic phenotype CTD_human A new manifestation and treatment alternative for heparin-induced thrombosis. 2123154 1990
Entrez Id: 5327
Gene Symbol: PLAT
PLAT 		0.320 Biomarker phenotype CTD_human A new manifestation and treatment alternative for heparin-induced thrombosis. 2123154 1990
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1 		0.510 Biomarker phenotype CTD_human Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome. 2133253 1990
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1 		0.510 Therapeutic phenotype CTD_human Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome. 2133253 1990
Entrez Id: 5328
Gene Symbol: PLAU
PLAU 		0.500 Therapeutic phenotype CTD_human Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome. 2133253 1990
Entrez Id: 5328
Gene Symbol: PLAU
PLAU 		0.500 Therapeutic phenotype CTD_human Intraoperative infusion of lytic drugs for thrombotic complications of revascularization. 2795766 1989
Entrez Id: 7450
Gene Symbol: VWF
VWF 		0.340 Biomarker phenotype CTD_human Altered von Willebrand factor molecule in children with thrombosis following asparaginase-prednisone-vincristine therapy for leukemia. 3875694 1985
Entrez Id: 5328
Gene Symbol: PLAU
PLAU 		0.500 Therapeutic phenotype CTD_human The urokinase-pulmonary embolism trial. 4884574 1969
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1 		0.510 Biomarker phenotype CTD_human Estrogen treatment of tall girls: risk of thrombosis? 6889048 1983
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1 		0.510 Therapeutic phenotype CTD_human Estrogen treatment of tall girls: risk of thrombosis? 6889048 1983
Entrez Id: 5196
Gene Symbol: PF4
PF4 		0.310 Biomarker phenotype CTD_human These findings indicate that antibodies associated with HITP react with PF4 complexed with heparin in solution or with glycosaminoglycan molecules on the surface of endothelial cells and provide the basis for a new hypothesis to explain the development of thrombocytopenia with thrombosis or disseminated intravascular coagulation in patients sensitive to heparin. 8282825 1994
Entrez Id: 2243
Gene Symbol: FGA
FGA 		0.500 Biomarker phenotype CTD_human Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia. 8473507 1993
Entrez Id: 5328
Gene Symbol: PLAU
PLAU 		0.500 Therapeutic phenotype CTD_human Pulmonary emboli from pulse-spray and mechanical thrombolysis: evaluation with an animal dialysis-graft model. 8657906 1996
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1 		0.510 Therapeutic phenotype CTD_human [Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test]. 8967151 1996
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1 		0.510 Biomarker phenotype CTD_human [Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test]. 8967151 1996
Entrez Id: 5624
Gene Symbol: PROC
PROC 		0.340 Biomarker phenotype CTD_human Even in these risk groups, the cost-benefit ratio of selective screening is unfavorable, as today at most 70% of the hereditary thrombophilias can be diagnosed by laboratory analysis, and only very few of the patients will actually experience a thrombotic event: only 3 of 1000 carriers of APC-resistance will suffer from thrombosis during oral contraception. 8967151 1996
Entrez Id: 2153
Gene Symbol: F5
F5 		0.380 Biomarker phenotype CTD_human Lipoprotein (a): its role in childhood thromboembolism. 9164807 1997
Entrez Id: 5624
Gene Symbol: PROC
PROC 		0.340 Biomarker phenotype CTD_human Lipoprotein (a): its role in childhood thromboembolism. 9164807 1997
Entrez Id: 5196
Gene Symbol: PF4
PF4 		0.310 Biomarker phenotype CTD_human Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin: platelet factor 4. 9446652 1998